TIFFANY WALLACE: Open Payments
NPI 1942804612 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 51 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $792 · 2025 $1,064
Food & beverage: $906Education: $158
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $199 |
| Astellas Pharma US Inc | 5 | $188 |
| Evofem Biosciences, Inc. | 12 | $172 |
| Lilly USA, LLC | 5 | $170 |
| Amgen Inc. | 11 | $143 |
| Novo Nordisk Inc | 3 | $62 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| MILLICENT US INC | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Phexxi, ZEPBOUND, EVENITY, ANNOVERA, Wegovy, ACCRUFER, Veozah, INTRAROSA.
Industry payments across NC — which companies pay providers there.
